Picture of Heidelberg Pharma AG logo

HPHA Heidelberg Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Heidelberg Pharma AG: 9M Earnings Per Share 0.34 EUR Vs 0.39 EUR Year Ago

Oct 12 (Reuters) - Heidelberg Pharma Ag  HPHA.DE :
    * NINE MONTHS EARNINGS PER SHARE 0.34 EUR VERSUS 0.39 EUR
YEAR AGO
    * HDP-101 CLINICAL TRIAL IN EUROPE AND US CONTINUES WITH
ADJUSTED
PROTOCOL AND LARGER NUMBER OF STUDY SITES IN EUROPE
    * FIFTH PATIENT COHORT INITIATED AT 100 ΜG/KG DOSING
    * PATIENT FROM THIRD COHORT CONTINUES TO BE DOSED AND SHOWS
STABLE
DISEASE
    * DIVESTMENT OF MINORITY STAKE IN EMERGENCE LEADS TO HIGHER
OTHER
INCOME AND ADDITIONAL CASH INFLOWS
    * SALES AND OTHER INCOME ABOVE PLAN, OTHER FINANCIALS IN
LINE WITH
PLAN

Source text for Eikon:  ID:nEQ36mkHba 
Further company coverage:  HPHA.DE 

 (Reporting by Berlin Newsroom)
 ((berlin.newsroom@thomsonreuters.com;))

Recent news on Heidelberg Pharma AG

See all news